Part 10/13:
Talking to Dr. Oz, the program’s guest and a key healthcare figure, the discussion shifted to President Trump’s “Trump RX” initiative. The plan aims to reduce prescription drug costs through direct negotiation with pharmaceutical giants like Pfizer, AstraZeneca, and Amgen. Dr. Oz explained that the new strategy intends to bring U.S. drug prices in line with those of other developed nations, addressing a long-standing concern about exorbitant medication costs.
The initiative also involves establishing a website that connects consumers directly with drug manufacturers or stores, promoting transparency and price comparison. Major pharmacy benefit management companies are also shifting towards transparent rebate policies, a move seen as beneficial to consumers eager for better pricing options.